Immunological link between primary graft dysfunction and chronic lung allograft rejection.

Area of Science:

• Transplant Immunology
• Pulmonary Medicine
• Allograft Rejection

Background:

• Primary graft dysfunction (PGD) is a significant risk factor for chronic lung transplant rejection, specifically bronchiolitis obliterans syndrome (BOS).
• The underlying mechanisms linking PGD to BOS are not fully understood but are suspected to involve augmented alloimmunity.

Purpose of the Study:

• To investigate the hypothesis that PGD-induced inflammation enhances alloimmunity, predisposing lung transplant recipients to BOS.
• To explore the relationship between PGD severity, inflammatory mediators, and the development of anti-human leukocyte antigen (HLA) alloantibodies and T-cell responses.

Main Methods:

• Diagnosis of PGD and BOS followed International Society for Heart and Lung Transplantation criteria.
• Analysis of anti-HLA alloantibodies using Flow-PRA and donor HLA class II-specific T cells via IFN-gamma ELISPOT.
• Quantification of 25 serum cytokines and chemokines using LUMINEX assays.

Main Results:

• Patients with PGD (grades 1-3) exhibited elevated levels of proinflammatory mediators (MCP-1, IP-10, IL-1β, IL-2, IFN-γ, IL-12) compared to those without PGD (grade 0).
• PGD patients showed a significantly higher incidence of de novo anti-HLA class II antibodies (52.2% vs. 13.5% at 5 years) and increased frequency of donor HLA class II-specific CD4+ T cells.
• No significant difference in anti-HLA class I alloantibody development was observed between PGD groups.

Conclusions:

• PGD triggers proinflammatory cytokines that upregulate donor HLA class II antigens on the allograft.
• This upregulation, combined with PGD-induced inflammation, promotes donor-specific alloimmunity.
• These findings establish a mechanistic link between early lung allograft injury (PGD) and the development of BOS.